The Med-Tech company PolarCool AB (publ.) has signed a two-year agreement with the Top 14 club USA Perpignan. The agreement means that 7 out of 14 clubs in France's top rugby league now utilize PolarCap® for the treatment of players suffering from concussions.

USA Perpignan joins the growing number of French rugby clubs providing the PolarCap® System, reflecting an increasing prioritization of concussion management and player safety within the rugby world. In the leading French rugby league, Aviron Bayonnais, Stade Français, Racing 92, Lyon Olympique, ASM Clermont, and US Oyonnax are providing concussion treatment with PolarCap®. The agreement highlights the potential of the French rugby market, which includes a total of 30 professional teams across the Top 14 and Pro D2, as well as over 1,800 amateur teams.

Erik Andersson, PolarCool's CEO comments;

-We are pleased to witness the continued growth in interest for PolaCap®. We are delighted that USA Perpignan is now offering the PolarCap® System to its players, further strengthening our position in the French rugby market. We look forward to continuing our establishment both in the French market and across Europe.

The agreement with USA Perpignan is strategically significant, even if the financial impact of individual agreements is limited.

For more information

Erik Andersson –  CEO PolarCool AB (publ.)               
+46 - 738 60 57 00                                         
E-mail: erik.andersson@polarcool.se

About PolarCool AB (publ.)

PolarCool AB (publ.) is a medical device company that develops, markets, and sells products for sports medicine. The company focuses on treatment of concussive and sub-concussive brain injury with the portable cooling device PolarCap® System. PolarCool AB (publ.) is based in Lund, Sweden, and its shares are listed on Spotlight Stock Market.